Cut‐Point Levels of Phosphatidylethanol to Identify Alcohol Misuse in a Mixed Cohort Including Critically Ill Patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Alcoholism: Clinical and Experimental Research

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/acer.13471PMID 28792620PMCID PMC5626634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice.

  2016cited by this paper
• Phosphatidylethanol (PEth) in blood samples from “driving under the influence” cases as indicator for prolonged excessive alcohol consumption

  2016cited by this paper
• Alcohol exposure, injury, and death in trauma patients

  2015cited by this paper
• Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.

  2015cited by this paper
• Ethanol metabolites: their role in the assessment of alcohol intake.

  2015cited by this paper
• Brief Versus Full Alcohol Use Disorders Identification Test in National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network Clinical Trials

  2015cited by this paper
• Quantification of phosphatidylethanol 16:0/18:1, 18:1/18:1, and 16:0/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers

  2015cited by this paper
• The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure.

  2014cited by this paper
• Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

  2014cited by this paper
• Blood alcohol content, injury severity, and adult respiratory distress syndrome

  2014cited by this paper
• Contribution of Excessive Alcohol Consumption to Deaths and Years of Potential Life Lost in the United States

  2014cited by this paper
• Progress in monitoring alcohol consumption and alcohol abuse by phosphatidylethanol.

  2014cited by this paper
• Comparison of direct and indirect alcohol markers with PEth in blood and urine in alcohol dependent inpatients during detoxication

  2013cited by this paper
• Alcohol Screening Scores and 90-Day Outcomes in Patients With Acute Lung Injury

  2013cited by this paper
• Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: U.S. Preventive Services Task Force Recommendation Statement

  2013cited by this paper
• Stability of phosphatidylethanol species in spiked and authentic whole blood and matching dried blood spots

  2013cited by this paper
• AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers.

  2013cited by this paper
• [National harmonization of the alcohol biomarker PEth].

  2013cited by this paper
• Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.

  2012cited by this paper
• Phosphatidylethanol in Blood as a Marker of Chronic Alcohol Use: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Liquid Chromatography-Tandem Mass Spectrometry Assay to Detect Ethyl Glucuronide in Human Fingernail: Comparison to Hair and Gender Differences.

  2012cited by this paper
• The Detection of 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol and Ethyl Glucuronide in Human Umbilical Cord

  2012cited by this paper
• Prolonged urinary detection times of EtG and EtS in patients with decreased renal function.

  2012cited by this paper
• Dose-response relationship between in-hospital mortality and alcohol following acute injury.

  2012cited by this paper
• Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days.

  2012cited by this paper
• Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse.

  2011cited by this paper
• Detection of Phosphatidylethanol (PEth) in the Blood of Drivers in an Alcohol Ignition Interlock Program

  2011cited by this paper
• Economic costs of excessive alcohol consumption in the U.S., 2006.

  2011cited by this paper
• The Association Between Blood Alcohol Level and Infectious Complications Among Burn Patients

  2009cited by this paper
• Alcohol and risk of mortality in patients with traumatic brain injury.

  2009cited by this paper
• NHS still failing to tackle alcohol misuse despite rise in admissions

  2009cited by this paper
• Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.

  2009cited by this paper
• The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting.

  2008cited by this paper
• Adverse Clinical Outcomes Associated With Elevated Blood Alcohol Levels at the Time of Burn Injury

  2008cited by this paper
• BIOMARKER: Phosphatidylethanol as a sensitive and specific biomarker—comparison with gamma‐glutamyl transpeptidase, mean corpuscular volume and carbohydrate‐deficient transferrin

  2007cited by this paper
• The alcohol use disorders identification test: an update of research findings.

  2007cited by this paper
• Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients*

  2007cited by this paper
• AUDIT-C as a brief screen for alcohol misuse in primary care.

  2007cited by this paper
• The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

  2006cited by this paper
• Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study.

  2006cited by this paper
• Actual causes of death in the United States, 2000.

  2004cited by this paper
• Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department.

  2004cited by this paper
• Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

  2001cited by this paper
• Can ethyl glucuronide be determined in post-mortem body fluids and tissues?

  1999cited by this paper
• The impact of alcohol-related diagnoses on pneumonia outcomes.

  1997cited by this paper
• Identifying hazardous or harmful alcohol use in medical admissions: a comparison of audit, cage and brief mast.

  1996cited by this paper
• The magnitude of acute and chronic alcohol abuse in trauma patients.

  1993cited by this paper
• The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma.

  1993cited by this paper
• Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

  1993cited by this paper

• Identification of hazardous alcohol use in outpatient psychiatric care: A comparison of biomarker phosphatidylethanol (PEth) and self-report.

  2026cites this paper
• Systemic serum protein alterations and molecular mechanisms in alcohol dependence

  2026cites this paper
• Alcohol Relapse After Liver Transplantation: Advances in Risk Stratification, Biomarker Integration, and Post-Transplant Care

  2025cites this paper
• PEth Cut‐Off Thresholds for Hazardous Alcohol Consumption Based on a Drinking Study

  2025cites this paper
• An improved and economical LLE-LC/MS method for quantifying phosphatidylethanol: Identification and separation of isotopic cross-talk in clinical alcohol testing.

  2025cites this paper
• Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with alcohol use disorder and liver disease at a liver transplant center

  2025cites this paper
• Recent Alcohol Use Influences Associations between Cortisol Levels and Negative Affect: The New Orleans Alcohol Use in HIV Study

  2025cites this paper
• Le phosphatidyléthanol, nouveau marqueur de l’éthylisme chronique

  2025cites this paper
• Association of Central Nervous System-Related Biomarkers With Hospital Delirium in Patients With Respiratory Failure in the ICU

  2025cites this paper
• Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective.

  2025cites this paper
• Measurement of central nervous system related biomarkers in plasma of burn patients.

  2025cites this paper
• Prevalence of Alcohol Use Characterized by Phosphatidylethanol in Patients With Respiratory Failure Before and During the COVID-19 Pandemic

  2024cites this paper
• Phosphatidylethanol measures in patients with severe COVID-19-associated respiratory failure identify a subset with alcohol misuse.

  2024cites this paper
• Relationship between alcohol intake based on daily smartphone-reported consumption and PEth concentrations in healthy volunteers

  2024cites this paper
• Moderate-to-severe cognitive impairment is associated with both recent and chronic alcohol misuse in people with HIV: The New Orleans alcohol use in HIV (NOAH) study.

  2024cites this paper
• Behandlungsstrategien bei Patient:innen mit Alkoholkonsumstörung und eingeschränkter Leberfunktion

  2024cites this paper
• Recent alcohol intake impacts microbiota in adult burn patients.

  2024cites this paper
• Management of Alcohol-Associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.

  2024cites this paper
• Phosphatidylethanol and self-reported alcohol consumption among people living with HIV in Thai Nguyen, Vietnam.

  2023cites this paper
• Aberrant Inflammatory Responses in Intoxicated Burn Injured Patients Parallel Impaired Cognitive Function.

  2023cites this paper
• Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population

  2023cites this paper
• Phosphatidylethanol (PEth) in Blood as a Marker of Unhealthy Alcohol Use: A Systematic Review with Novel Molecular Insights

  2023influential citation
• Impact of Alcohol Misuse on Requirements for Critical Care Services and Development of Hospital Delirium in Patients With COVID-19 pneumonia

  2023cites this paper
• “But I didn’t drink!”: What to do with discordant phosphatidylethanol results

  2023cites this paper
• Quantifying Alcohol Consumption in the General Population by Analysing Phosphatidylethanol Concentrations in Whole Blood: Results from 24,574 Subjects Included in the HUNT4 Study

  2023cites this paper
• Preoperative alcohol interventions for elective surgical patients: Results from a randomized pilot trial.

  2022cites this paper
• Set-up of a population-based model to verify alcohol abstinence via monitoring of the direct alcohol marker phosphatidylethanol 16:0/18:1.

  2022cites this paper
• Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for erythrocyte phosphatidylethanol revealing critical considerations for its use as a clinical biomarker.

  2022cites this paper
• Identification of unhealthy alcohol use by self-report and phosphatidylethanol (PEth) blood concentrations in an acute psychiatric department

  2022cites this paper
• The correlates of high phosphatidylethanol (PEth) levels and its concordance with self-reported heavy alcohol consumption among men who have sex with men who binge drink alcohol.

  2022cites this paper
• Phosphatidylethanol in Maternal or Neonatal Blood to Detect Alcohol Exposure during Pregnancy: A Systematic Review

  2022cites this paper
• Clinical and diagnostic value of alcohol biomarkers

  2022cites this paper
• Development and validation of seven phosphatidylethanol-homologues in dried blood spots including preliminary results after excessive use of an ethanol-based hand sanitizer

  2022cites this paper
• Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow-back.

  2022cites this paper
• The Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients

  2021cites this paper
• Internal and External Validation of an Alcohol Biomarker for Screening in Trauma

  2021cites this paper
• Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement

  2021cites this paper
• The effects of preoperative alcohol, tobacco, and psychological stress on postoperative complications: a prospective observational study

  2021cites this paper
• Alcohol and the global burden of cancer: what are we missing?

  2021cites this paper
• Relationship of Phosphatidylethanol (PEth) Biomarker to Self-Reported Alcohol Drinking Patterns in Older and Middle Age Adults.

  2020influential citation
• Blood phosphatidyl ethanol levels as a tool to detect alcohol misuse in trauma patients

  2020cites this paper
• Comprehensive Assessment of Alcohol Consumption in People Living with HIV (PLWH): The New Orleans Alcohol Use in HIV Study.

  2020cites this paper
• The roles of phosphatidylethanol (PEth), ethyl glucuronide (EtG), and ethyl sulfate (EtS) in identifying alcohol consumption among participants in professionals' health programs.

  2020cites this paper
• Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence

  2020cites this paper
• Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients.

  2020cites this paper
• Prevalence of risk—drinking in critically ill patients, screened with carbohydrate‐deficient transferrin and AUDIT‐C score: A retrospective study

  2020cites this paper
• Aktuelles zu Alkoholkonsum- markern bei forensischen und suchtmedizinischen Fragestellungen

  2020cites this paper
• Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence

  2020cites this paper
• Comparison of the Diagnostic Value of Phosphatidylethanol and Carbohydrate-Deficient Transferrin as Biomarkers of Alcohol Consumption.

  2020cites this paper
• Injury Characteristics and von Willebrand Factor for the Prediction of Acute Respiratory Distress Syndrome in Patients With Burn Injury: Development and Internal Validation.

  2019cites this paper
• Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption

  2019cites this paper
• Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.

  2019cites this paper
• Harmful alcohol use among acutely ill hospitalized medical patients in Oslo and Moscow: A cross-sectional study.

  2019cites this paper
• Inter-Individual Variation and Factors regulating the Formation of Phosphatidylethanol (PEth).

  2019cites this paper
• Differentiating Types of Self-Reported Alcohol Abstinence

  2019cites this paper
• Should phosphatidylethanol be currently analysed using whole blood, dried blood spots or both?

  2019cites this paper
• Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model

  2018cites this paper
• Letter to the Editor Regarding Afshar et al. (2017): Cut-Point Levels of Phosphatidylethanol to Identify Alcohol Misuse in a Mixed Cohort Including Critically Ill Patients.

  2018cites this paper
• Use of alcohol biomarkers to identify alcohol misuse in organ donors.

  2018cites this paper
• Internal and External Validation of an Alcohol Biomarker for Internal and External Validation of an Alcohol Biomarker for Screening in Trauma Screening in Trauma

  year unknowncites this paper